PROMinsight, a spin-off from the Singapore Eye Research Institute (SERI) and Duke-NUS Medical School, is transforming the way patient care is delivered through its AI-driven adaptive tools. These tools, including MyoRI-CAT, GlauCAT-Asian, and MacCAT, are designed to teach interpretation of patient-reported outcomes, enabling healthcare professionals to make empathetic, data-informed decisions.
TL;DR
PROMinsight develops AI-driven adaptive tools for patient care.
These tools enhance empathetic decision-making and provide accurate assessments.
PROMinsight's technology has the potential to transform patient care.
The company's innovative approach is poised to make a significant impact in the healthcare industry.
Introduction to PROMinsight
PROMinsight’s innovative approach focuses on capturing patients’ quality of life through AI-driven, computerized adaptive tests (CATs). These CATs adapt to patients’ previous answers, selecting the most relevant questions to provide accurate and efficient assessments.
The use of PROMinsight’s adaptive tools has shown significant benefits in clinical trials and healthcare settings. By providing precise and meaningful insights into patients’ quality of life, these tools enable healthcare professionals to make informed decisions, leading to better patient outcomes and improved care.
Author Quote"
PROMinsight’s Co-Founder and Chief Scientific Adviser, Professor Ecosse Lamoureux, notes that ‘AI-enabled computerized PROMs are still rarely used in eye care, but our tools are poised to make a significant impact in the healthcare industry.’
"
Not applicable - no significant bias identified
Applications and Future Directions
PROMinsight’s technology has the potential to revolutionize patient care across various medical specialties. With its AI-driven adaptive tools, PROMinsight is poised to make a significant impact in the healthcare industry, enabling healthcare professionals to deliver more effective, patient-centered care.
Key Takeaways:
1
PROMinsight's adaptive tools enhance empathetic decision-making in patient care.
AI-driven computerized adaptive tests (CATs) provide accurate and efficient assessments.
PROMinsight's technology has the potential to revolutionize patient care across various medical specialties.
Conclusion
In conclusion, PROMinsight’s innovative approach to patient care is transforming the way healthcare professionals make decisions. By leveraging AI-driven adaptive tools, PROMinsight is enabling more empathetic, data-informed decision-making, leading to better patient outcomes and improved care.
By leveraging PROMinsight’s innovative technology, healthcare professionals can deliver more effective, patient-centered care. Learn more about how PROMinsight is transforming patient care and discover the potential of AI-driven adaptive tools in healthcare.
Is Your Child Struggling in School?
Get Your FREE Personalized Learning Roadmap
Comprehensive assessment + instant access to research-backed strategies